AbbVie (BSP:ABBV34) Total Liabilities : R$609,114 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AbbVie Total Liabilities?

AbbVie's Total Liabilities for the quarter that ended in Dec. 2023 was R$609,114 Mil.

AbbVie's quarterly Total Liabilities increased from Jun. 2023 (R$594,427.79 Mil) to Sep. 2023 (R$612,853.16 Mil) but then declined from Sep. 2023 (R$612,853.16 Mil) to Dec. 2023 (R$609,113.74 Mil).

AbbVie's annual Total Liabilities declined from Dec. 2021 (R$741,317.81 Mil) to Dec. 2022 (R$637,410.52 Mil) and declined from Dec. 2022 (R$637,410.52 Mil) to Dec. 2023 (R$609,113.74 Mil).

AbbVie Total Liabilities Historical Data

The historical data trend for AbbVie's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie Total Liabilities Chart

AbbVie Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

399,314.49

707,231.62

741,317.81

637,410.52

609,113.74

AbbVie Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															631,495.87	594,427.79	612,853.16	609,113.74	-

AbbVie Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

AbbVie's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	185413.332	+	(255740.161	+	150859.942
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	9564.41	+	7535.892)
	=	609,114

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	660056.958	-	50943.221
	=	609,114

AbbVie's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	185413.332	+	(255740.161	+	150859.942
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	9564.41	+	7535.892)
	=	609,114

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	660056.958	-	50943.221
	=	609,114

AbbVie Total Liabilities Related Terms

Thank you for viewing the detailed overview of AbbVie's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie (BSP:ABBV34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV:Austria

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

http://www.abbvieinvestor.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (BSP:ABBV34) Headlines

No Headlines